Ticker Scorecard - RNA Basics Company: Avidity Biosciences, Inc. IPO Date: June 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $3.71B Activated in VL: True Average Daily Range Avg Daily Range: $0.72 | 3.30% Avg Daily Range (30 D): $0.72 | 2.30% Avg Daily Range (90 D): $1.06 | 2.72% Institutional Daily Volume Avg Daily Volume: .65M Avg Daily Volume (30 D): 1.15M Avg Daily Volume (90 D): .98M Trade Size Avg Trade Size (Sh.): 77 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 1,949 Avg Inst. Trade: $2.68M Avg Inst. Trade (30 D): $2.48M Avg Inst. Trade (90 D): $2.94M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.39M Avg Closing Trade (30 D): $4.95M Avg Closing Trade (90 D): $6.02M Avg Closing Volume: 143.16K     News Jul 1, 2024 @ 5:38 PM Top Performing Industry ETFs In June: Software Lea... Source: Piero Cingari Jun 13, 2024 @ 2:39 PM Avidity (RNA) Up 33% on Rare Muscle Disease Study ... Source: Zacks Equity Research Jun 10, 2024 @ 12:01 PM A Glimpse Into The Expert Outlook On Avidity Biosc... Source: Benzinga Insights May 29, 2024 @ 12:45 PM 2 Potentially High-Reward Growth Stocks to Buy Rig... Source: newsfeedback@fool.com (George Budwell) May 9, 2024 @ 9:15 PM Coherus BioSciences (CHRS) Reports Q1 Loss, Misses... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.89 $-.65 $-.65 Diluted EPS $-2.89 $-.65 $-.65 Revenue $ 10.12M $ 2.34M $ 2.05M Gross Profit $ $ $ Net Income / Loss $ -280.49M $ -80.4M $ -70.79M Operating Income / Loss $ -324.69M $ -98.13M $ -82.63M Cost of Revenue $ $ $ Net Cash Flow $ 287.04M $ -205.56M $ 106.85M PE Ratio